glp-1-directed nmda receptor antagonism for obesity treatment GLP1 Agonists—Effects beyond and Diabetes Emerging Role of GLP-1 Receptor

Impact of the natural compound urolithin A on health, disease, and aging

kids live with parents with substance use disorders People taking semaglutide had lower risk of suicidal thoughts Scientists find common brain network for substance use disorders Few are prescribed medications to treat alcohol problems Repurposed drug combats obesity in mice Alcohol-related deaths increasing nationwide Understanding alcohol use disorder Understanding alcohol drinking patterns Alcohol treatment navigator References Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial

The American Academy of Pediatrics and several international professional organizations recommend that all babies receive 0.5 to 1.0 mg intramuscular vitamin K 1 injection shortly after birth to prevent VKDB (122, 124, 125, 130-132)

Related PDB-101 Resources Browse Drug Action Browse Cancer Browse Molecules for a Sustainable Future Browse Toxins and Poisons References 3zmk, 3zml: JM Riveron, C Yunta, SS Ibrahim, R Djouaka, H Irving, BD Menze, HM Ismail, J Hemingway, H Ranson, A Albert & CS Wondji (2014) A single mutation in the GSTe2 gene allows tracking of metabolically based insecticide resistance in a major malaria vector

Thioredoxin-thioredoxin reductase system in Lb